Montelukast Sodium Salt is a fully characterized chemical compound used as a reference standard of API Lumacaftor. The standard offered is compliant with regulatory guidelines. Montelukast Sodium Salt is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - NA
Related products
Montelukast Cyclopropacetaneamide Impurity
M.F. C₃₅H₃₇ClN₂O₂S
M.W. 585.21
CAT# AR-M02238
CAS# 866923-63-9
Montelukast methyl methanesulfonate fragment Impurity
M.F. C₇H₁₁NO₃S
M.W. 189.2
CAT# AR-M03441
CAS# 152922-86-6
Montelukast EP Impurity A Sodium Salt
M.F. C₃₅H₃₅ClNO₃S. Na
M.W. 585.18; 22.99
CAT# AR-M02235
CAS# 190078-45-6
Montelukast Dicyclohexylamine Salt
M.F. C₃₅H₃₆ClNO₃S C₁₂H₂₃N
M.W. 586.18 181.32
CAT# AR-M02482
CAS# 577953-88-9
Montelukast (3S)-Hydroxy Benzoate with TBC as stabilizer
M.F. C₂₈H₂₄ClNO₃
M.W. 457.96
CAT# AR-M02247
CAS# 142569-69-5
Montelukast R,S-Isomer (Montelukast EP Impurity E)
M.F. C₄₁H₄₆ClNO₅S₂
M.W. 732.39
CAT# AR-M02230
CAS# 1187586-58-8
Montelukast EP Impurity C (Montelukast Sulfoxide)
M.F. C₃₅H₃₆ClNO₄S
M.W. 602.18
CAT# AR-M19061
CAS# 909849-96-3
Montelukast Sulfoxide (Mixture of Diastereomers)
M.F. C₃₅H₃₆ClNO₄S
M.W. 602.19
CAT# AR-M02227
CAS# 1152185-58-4
Montelukast Racemate Dicyclohexylamine
M.F. C₃₅H₃₆ClNO₃S : C₁₂H₂₃N
M.W. 586.2 : 181.3
CAT# AR-M03628
CAS# NA
Montelukast Dihydro Impurity Na Salt
M.F. C₃₅H₃₈ClNO₃S : Na
M.W. 588.2
CAT# AR-M03572
CAS# 142147-98-6
Montelukast EP Impurity B Sodium Salt
M.F. C₃₅H₃₃ClNO₂S : Na
M.W. 567.16; 22.99
CAT# AR-M03214
CAS# 1146137-52-1
